These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 28052770

  • 21. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
    Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M.
    Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
    Lin JT, Tzai TS, Liao CY, Wang JS, Wu TT, Wang HY, Wu CH, Yu CC, Lu PJ.
    Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
    [Abstract] [Full Text] [Related]

  • 24. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q, Cheng G, Liu Y, Xu T, Zhang H, Li B.
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [Abstract] [Full Text] [Related]

  • 25. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Bao X, Duan J, Yan Y, Ma X, Zhang Y, Wang H, Ni D, Wu S, Peng C, Fan Y, Gao Y, Li X, Chen J, Du Q, Zhang F, Zhang X.
    Cancer Biomark; 2017 Dec 12; 21(1):55-63. PubMed ID: 29081406
    [Abstract] [Full Text] [Related]

  • 26. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.
    Eur J Cancer; 2011 Sep 12; 47(13):2068-76. PubMed ID: 21600761
    [Abstract] [Full Text] [Related]

  • 27. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH, Shi SN, Wang J, Xu Y, Tian X, Wan FN, Cao DL, Qu YY, Zhang HL, Ye DW.
    Med Sci Monit; 2019 Dec 11; 25():9458-9470. PubMed ID: 31825950
    [Abstract] [Full Text] [Related]

  • 28. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J, Krazinski BE, Kowalczyk AE, Kiewisz J, Kiezun J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Maslowski Z, Kmiec Z.
    Anticancer Res; 2016 Feb 11; 36(2):617-24. PubMed ID: 26851016
    [Abstract] [Full Text] [Related]

  • 29. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
    Wu X, Lin Y, Shi L, Huang Y, Lai C, Wang Y, Zhang M, Wang S, Heng B, Yu G, Du X, Fang L, Fu Y, Chen J, Guo Z, Su Z, Wu S.
    J Mol Histol; 2015 Oct 11; 46(4-5):377-85. PubMed ID: 26248586
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.
    Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.
    Cancer Biol Ther; 2014 Mar 01; 15(3):329-41. PubMed ID: 24351440
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R, Droschl N, Tauber V, Rehak P, Langner C.
    Urology; 2006 Sep 01; 68(3):518-22. PubMed ID: 16979727
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Lin W, Chen X, Chen T, Liu J, Ye Y, Chen L, Qiu X, Chia-Hsien Cheng J, Zhang L, Wu J, Qiu S.
    DNA Cell Biol; 2020 Jun 01; 39(6):1000-1011. PubMed ID: 32282241
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.
    Porubsky S, Nientiedt M, Kriegmair MC, Siemoneit JH, Sandhoff R, Jennemann R, Borgmann H, Gaiser T, Weis CA, Erben P, Hielscher T, Popovic ZV.
    Sci Rep; 2021 May 25; 11(1):10926. PubMed ID: 34035403
    [Abstract] [Full Text] [Related]

  • 39. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA, Love HD, Guo S, Gellert L, Chang SS, Herrell SD, Barocas DA, Penson DF, Cookson MS, Clark PE.
    Urol Oncol; 2017 May 25; 35(5):286-293. PubMed ID: 28108243
    [Abstract] [Full Text] [Related]

  • 40. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X, Gu L, Li H, Gao Y, Li X, Shen D, Gong H, Li S, Niu S, Zhang Y, Fan Y, Huang Q, Lyu X, Zhang X.
    J Transl Med; 2015 Feb 12; 13():56. PubMed ID: 25740019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.